Guardian Pharmacy Services (GRDN) EBITDA (2023 - 2026)

Guardian Pharmacy Services has reported EBITDA for 4 years, with the latest figure at $17.7 million in Q1 2026.

• Quarterly EBITDA rose 35.91% year-over-year to $17.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.4 million (up 233.75% YoY) and the FY2025 annual result came in at $72.7 million, up 215.55% from the prior year.
• EBITDA fell to $17.7 million in Q1 2026 per GRDN's latest filing, from $30.8 million in the prior quarter.
• Over five years, EBITDA peaked at $30.8 million in Q4 2025 and troughed at -$104.6 million in Q3 2024.
• A 4-year average of $3.3 million and a median of $15.5 million in 2023 frame the typical range for EBITDA.
• The sharpest annual moves came in 2024 and 2025: EBITDA tumbled 1552.65% in 2024, then jumped 115.63% in 2025.
• Over 4 years, EBITDA stood at $15.5 million in 2023, then grew by 7.93% to $16.8 million in 2024, then jumped by 83.6% to $30.8 million in 2025, then sank by 42.54% to $17.7 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $17.7 million, $30.8 million, and $16.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.